Journal
RADIOLOGY
Volume 251, Issue 2, Pages 309-310Publisher
RADIOLOGICAL SOC NORTH AMERICA
DOI: 10.1148/radiol.2512090268
Keywords
-
Ask authors/readers for more resources
Although the translation of experimental molecular MR imaging agents is highly compelling, it is substantially more complex than the translation of radiolabeled imaging agents. The prognostic value, safety, and cost-effectiveness of molecular MR imaging for the detection of plaque inflammation will need to be demonstrated and will require a robust and collaborative effort among basic scientists, clinicians, epidemiologists, and industry. The well-conducted and valuable study reported by Amirbekian et al (1) in this issue of Radiology adds further momentum to this important endeavor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available